GVK Extends Database License to FDA | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GVK Biosciences today said that it has extended its license for its Clinical Biomarker Database to the US Food and Drug Administration.

The extension is for a license, originally forged in 2007, to the database with FDA's Biomarker Qualification Group.

Financial and other terms of the extension were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.

South African researchers uncover bone cancer in an ancient hominin ancestor.

English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.

Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.